WT1 and biliary tract neoplasm: In one study using a WT1 peptide vaccine and gemcitabine combination therapy for pancreatic and biliary tract cancers, including eight patients with advanced CCA and eight with advanced GBC, the disease control rate in biliary tract cancer was 50% and median overall survival was 278 days [137].